RE:RE:cash burn Auxly has cut SG&A and tightened up on operating costs. Tripling production capacity at Dosecann and continued automation improvements will reduce costs even more.
Auxly generated $55mil in revenues in 2020. That was their first full year of sales with entry into Cannabis 2.0.
Improved revenues, higher margins, expanded market share and a fully functioning market place are the most direct potential opportunities to for Auxly to become profitable and turn from cash burn to cash earn.
The sale of KGK will have a direct effect as the doctors employed there and the salaries they earn will flow with the enterprise into the hands of the buyers.
The opening of Ontario and other major markets coming out of Covid should have a positive effect as well.
I have to agree with Oceanis that the moneys raised recently aren't strictly to cover operations.
I personally believe that it may have to do with Sunens defaulting and the need to cover the promisary note provided. Just a hunch.
Hang in there mates!
cheers